Patent infringement against subsidiary of industrial conglomerate

Patent infringement against subsidiary of industrial conglomerate

Health Care | Technology
Damages & Valuation | Intellectual Property

CRA provided analysis and expert testimony on behalf of a boutique healthcare technology company in a patent infringement case against the subsidiary of an industrial conglomerate. CRA determined total damages to be over $157 million which substantially exceeded the total revenues earned by the plaintiff throughout the life of its business. The jury agreed with our assessments and the court awarded judgment in favor of our client in excess of $164 million.